CLYM:NASDAQ
Climb Bio Inc
$14.95
arrow_downward
-0.66%(-0.10) 1D
$14.93
arrow_downward
-0.13% (-0.020)todayPre-market
Closed: Sep 10, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CLYM...
Open
$14.83
High
$15.07
Low
$14.16
Mkt. cap
858.67M
Avg. vol.
1.44M
Volume
194.00
52-wk high
$18.33
52-wk low
$1.54
EPS
-$0.82
Beta
0.12
Shares outstanding
57.44M
No. of employees
29
Open
$14.83
High
$15.07
Low
$14.16
Mkt. cap
858.67M
Avg. vol.
1.44M
Volume
194.00
52-wk high
$18.33
52-wk low
$1.54
EPS
-$0.82
Beta
0.12
Shares outstanding
57.44M
No. of employees
29
News stories
From web sources and news partners
TradingView
·
1 day ago
CLYM: Advancing two antibody assets in renal and autoimmune diseases, with pivotal trials ahead
Investing.com
·
2 days ago
H.C. Wainwright raises Climb Bio stock price target on drug data
Investing.com
·
2 days ago
Oppenheimer raises Climb Bio stock price target on IgAN data
About Climb Bio Inc
CEO-
Employees29
Founded2018
HeadquartersWellesley Hills, Massachusetts, United States
SectorBiotechnology
Websiteclimbbio.com